Provectus Biopharmaceuticals Inc (PVCT)

[236T568]

We are mailing this proxy statement, together with a form of proxy, on or about September 1, 2015.
At the Special Meeting, our stockholders will vote on a proposal to approve and adopt an amendment to our Certificate of Incorporation, as amended, to increase the number of shares of common stock, par value $.001 per share (“common stock”), that we are authorized to issue from 300,000,000 to 400,000,000 shares. This proposal is set forth in the accompanying Notice of Special Meeting of Stockholders and is described in more detail in this Proxy Statement. Stockholders also will transact any other business, not known or determined at the time of this proxy solicitation, that properly comes before the Special Meeting, although our Board of Directors knows of no such other business to be presented.


http://ih.advfn.com/p.php?pid=nmona&article=68259809&symbol=PVCT